Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,130,512
+$568,953 QoQ
Shares Held
2,610
-6.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#2,091
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cairn Investment Group, Inc. holds $15,565,541 across 7 Drug Manufacturers - General names. LLY ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
54,875 | $7,051,437 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,610 | $3,130,512 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
21,247 | $2,684,345 | |
| 4 | BIIB |
Biogen Inc.
|
8,043 | $1,737,770 | |
| 5 | NVO |
Novo Nordisk A S
|
9,333 | $447,424 | |
| 6 | JNJ |
Johnson & Johnson
|
1,060 | $269,208 | |
| 7 | ABBV |
AbbVie Inc.
|
973 | $244,845 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,130,512 | 2,610 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,561,559 | 2,785 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,207,920 | 2,985 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,277,555 | 2,985 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,326,897 | 2,985 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,465,341 | 2,985 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,343,020 | 3,035 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,127,368 | 3,530 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $3,300,110 | 3,645 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,785,096 | 3,580 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,320,021 | 3,980 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,151,742 | 4,006 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,866,540 | 3,980 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,366,811 | 3,980 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,551,527 | 4,241 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $1,170,527 | 3,620 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,314,752 | 4,055 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,901,783 | 6,641 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,837,139 | 6,651 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,562,129 | 6,761 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,551,784 | 6,761 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,731,074 | 9,266 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,631,163 | 9,661 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,347,130 | 9,101 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,533,605 | 9,341 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,396,355 | 10,066 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||